The article compares Kimberly-Clark and Clorox as investment options for 2026. Both companies face challenges including high debt loads, customer concentration risk (Walmart accounts for 16-27% of sales), and intense competition. Kimberly-Clark is undergoing significant restructuring with a potential $48 billion merger with Kenvue and selling its international tissue business, while Clorox is recovering from a 2023 cyberattack and pandemic-era slowdown. The author recommends Clorox as the safer choice due to its stronger brand positioning, though acknowledges Kimberly-Clark offers higher upside potential despite greater integration risks.

Kimberly-Clark Corporation has declared a regular quarterly dividend of $1.28 per share, payable on July 2, 2026. The company has maintained dividend payments for 92 consecutive years and increased its dividend for 54 consecutive years, demonstrating strong financial stability and commitment to shareholders.

Despite concerning market valuation signals like the Shiller P/E ratio at 41 and record cash holdings at Berkshire Hathaway, the author identifies three consumer dividend stocks with strong fundamentals: Realty Income (99% occupancy, 5.1% yield), Clorox (temporary headwinds but decades of dividend increases, 5.6% yield), and Kimberly-Clark (upcoming Kenvue merger, 54-year dividend streak, 5.2% yield). All three trade at attractive valuations relative to the broader market.

CJ Biomaterials and Yuhan-Kimberly have launched the Kleenex® Biodegradable Reusable Dishtowel, the world's first reusable nonwoven paper towel made with amorphous PHA technology. The 100% biobased product combines cellulose with CJ's proprietary PHACT™ A1000P material derived from sugarcane and is certified for home and commercial compostability without producing persistent microplastics. The product is now available in South Korea.

Three consumer goods dividend stocks are positioned for growth: Hershey benefits from a 74% drop in cocoa prices enabling margin expansion; General Mills offers a 7% yield amid transformation and cost structure improvements; Kimberly-Clark is acquiring Kenvue to create a scaled personal-care platform with strong brands and long-term dividend durability.

Kimberly-Clark is recommended as a defensive dividend stock for potential market downturns due to its essential consumer staples products, 54-year dividend increase streak, and attractive 5.2% yield. Despite a 30% stock price decline from its June high due to the $48.7 billion Kenvue acquisition financing concerns, the stock's low P/E ratio of 15 and strong free cash flow support suggest limited downside risk.

Hedge fund billionaire Daniel Loeb reduced his stake in Kenvue Inc. by 64% in Q4 2025, cutting holdings from 9.0 million to 3.25 million shares. The consumer health company, which includes brands like Tylenol and Listerine, is undergoing a restructuring that will reduce workforce by 3.5% with $250 million in charges expected in 2026. Kenvue's acquisition by Kimberly-Clark at $48.7 billion enterprise value is expected to close in H2 2026 pending regulatory approval.

The article examines five consumer staples stocks offering high dividend yields (up to 11%) despite sector challenges. While staples traditionally provide defensive value, recent inflation concerns and private-label competition have pressured these stocks. The five highlighted companies—Kimberly-Clark, Nomad Foods, Conagra Brands, Cal-Maine Foods, and Flowers Foods—offer attractive yields but face headwinds including input cost inflation, GLP-1 adoption impacts, and earnings pressures that could threaten dividend sustainability.

The article recommends three dividend stocks for investors seeking income: PepsiCo, which is showing signs of recovery after underperformance; Kenvue, a spinoff from Johnson & Johnson offering reliable recurring income with an upcoming merger; and Procter & Gamble, a consumer staples giant with 70 consecutive years of dividend increases.

While Costco and Walmart have delivered strong returns, their valuations are stretched with forward P/E ratios of 48.7 and 43.4 respectively, and low dividend yields of 0.5% and 0.8%. Kimberly-Clark offers a compelling alternative with a 5.3% dividend yield, 54 consecutive years of dividend increases, and a cheap valuation at 12.8x forward earnings. The company's strategic exit from low-margin private-label diapers and planned acquisition of Kenvue (adding brands like Band-Aid and Tylenol) position it for margin expansion and dividend growth.

Three Dividend Kings—Altria, Universal Corporation, and Kimberly-Clark—currently offer the highest dividend yields among elite dividend stocks that have increased dividends for 50+ consecutive years. Altria yields 6.3% but faces declining cigarette demand in North America. Universal yields 6.1% as a global tobacco supplier with stronger international demand. Kimberly-Clark yields 5.2% and is pursuing a growth strategy through its acquisition of Kenvue, though this carries integration risks. All three are considered riskier investments suitable primarily for aggressive investors.

Johnson & Johnson is highlighted as an exceptional dividend stock for retirees, boasting a 63-year dividend-increase streak as a Dividend King. The diversified healthcare company combines pharmaceutical and medical device businesses, with an AAA credit rating ensuring dividend stability. However, its 2.2% yield, while double the S&P 500's 1.1%, falls short of the 4% target many dividend investors seek.